10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32,615,513 | +41.5% | 895,047 | +10.6% | 0.01% | +33.3% |
| Q3 2022 | $23,049,861 | -29.4% | 809,335 | +12.2% | 0.01% | -25.0% |
| Q2 2022 | $32,653,712 | -40.1% | 721,629 | +0.7% | 0.01% | -33.3% |
| Q1 2022 | $54,532,149 | -50.2% | 716,868 | -2.6% | 0.01% | -47.8% |
| Q4 2021 | $109,597,000 | +1.0% | 735,751 | -1.3% | 0.02% | -4.2% |
| Q3 2021 | $108,516,000 | -16.4% | 745,406 | +12.5% | 0.02% | -14.3% |
| Q2 2021 | $129,769,000 | +65.6% | 662,693 | +53.1% | 0.03% | +55.6% |
| Q1 2021 | $78,345,000 | +3041.3% | 432,847 | +2064.2% | 0.02% | +1700.0% |
| Q3 2020 | $2,494,000 | +39.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,786,000 | +43.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,246,000 | -18.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,525,000 | +51.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,008,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |